BRPI0514043A - medicamentos para tratar doença respiratória crÈnica - Google Patents

medicamentos para tratar doença respiratória crÈnica

Info

Publication number
BRPI0514043A
BRPI0514043A BRPI0514043-9A BRPI0514043A BRPI0514043A BR PI0514043 A BRPI0514043 A BR PI0514043A BR PI0514043 A BRPI0514043 A BR PI0514043A BR PI0514043 A BRPI0514043 A BR PI0514043A
Authority
BR
Brazil
Prior art keywords
respiratory disease
medicines
treat chronic
chronic respiratory
treat
Prior art date
Application number
BRPI0514043-9A
Other languages
English (en)
Inventor
Craig Fox
Harry Finch
Mary Fitzgerald
Original Assignee
Argenta Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Argenta Discovery Ltd filed Critical Argenta Discovery Ltd
Publication of BRPI0514043A publication Critical patent/BRPI0514043A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

MEDICAMENTOS PARA TRATAR DOENçA RESPIRATóRIA CRÈNICA é possibilitado o uso de um composto de metilxantina e um esteróide em uma combinação sinergística para o tratamento de uma doença respiratória, em que o composto de metilxantina é administrado em uma dose que, isoladamente, não é eficaz para tratar a dita doença.
BRPI0514043-9A 2004-08-05 2005-08-03 medicamentos para tratar doença respiratória crÈnica BRPI0514043A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0417481.9A GB0417481D0 (en) 2004-08-05 2004-08-05 Combination therapy
PCT/GB2005/003039 WO2006013359A1 (en) 2004-08-05 2005-08-03 Medicaments for treating chronic respiratory disease

Publications (1)

Publication Number Publication Date
BRPI0514043A true BRPI0514043A (pt) 2008-05-27

Family

ID=32982599

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0514043-9A BRPI0514043A (pt) 2004-08-05 2005-08-03 medicamentos para tratar doença respiratória crÈnica

Country Status (15)

Country Link
US (1) US20080318912A1 (pt)
EP (1) EP1773342A1 (pt)
JP (1) JP2008509119A (pt)
CN (1) CN101035538A (pt)
AU (1) AU2005268668B2 (pt)
BR (1) BRPI0514043A (pt)
CA (1) CA2576107A1 (pt)
GB (2) GB0417481D0 (pt)
IL (1) IL180931A0 (pt)
MX (1) MX2007001567A (pt)
NO (1) NO20070597L (pt)
NZ (1) NZ552899A (pt)
RU (1) RU2395284C2 (pt)
WO (1) WO2006013359A1 (pt)
ZA (1) ZA200701007B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1802287A2 (en) * 2004-09-27 2007-07-04 Sigmoid Biotechnologies Limited Minicapsule formulations
GB2442828A (en) * 2005-02-11 2008-04-16 Argenta Discovery Ltd Combination of a methylxanthine compound and a steroid to treat chronic respiratory disease
ATE421325T1 (de) 2005-02-11 2009-02-15 Argenta Discovery Ltd Kombination von methylxanthinverbindungen und steroiden zur behandlung chronischer atemwegserkrankungen
US9084799B2 (en) 2005-02-11 2015-07-21 Pulmagen Therapeutics (Synergy) Limited Inhaled combination therapy
GB2430622B (en) * 2005-02-11 2008-03-05 Argenta Discovery Ltd Inhaled combination therapy
GB0603783D0 (en) * 2006-02-24 2006-04-05 Novartis Ag Organic compounds
ES2393814T3 (es) 2007-04-04 2012-12-28 Sigmoid Pharma Limited Una composición farmacéutica oral
CA2685118C (en) * 2007-04-26 2016-11-01 Sigmoid Pharma Limited Manufacture of multiple minicapsules
WO2008132712A2 (en) * 2007-05-01 2008-11-06 Sigmoid Pharma Limited Combination pharmaceutical compositions
ES2530049T3 (es) 2009-05-18 2015-02-26 Sigmoid Pharma Limited Composición que comprende gotas de aceite
CN102573802A (zh) 2009-08-12 2012-07-11 希格默伊德药业有限公司 包含聚合物基质和油相的免疫调节组合物
GB201020032D0 (en) 2010-11-25 2011-01-12 Sigmoid Pharma Ltd Composition
GB201113662D0 (en) 2011-08-08 2011-09-21 Prosonix Ltd Pharmaceutical compositions
GB201212010D0 (en) 2012-07-05 2012-08-22 Sigmoid Pharma Ltd Formulations
GB201304662D0 (en) 2013-03-14 2013-05-01 Sigmoid Pharma Ltd Compositions
GB201319791D0 (en) 2013-11-08 2013-12-25 Sigmoid Pharma Ltd Formulations
UA111983C2 (uk) * 2014-04-29 2016-07-11 Микола Іванович Гуменюк Фармацевтична композиція для лікування хронічних обструктивних захворювань легень
JP6716582B2 (ja) 2014-11-07 2020-07-01 サブリミティ・セラピューティクス・リミテッドＳｕｂｌｉｍｉｔｙ Ｔｈｅｒａｐｅｕｔｉｃｓ Ｌｉｍｉｔｅｄ シクロスポリンを含む組成物

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3622M (fr) * 1964-05-04 1965-10-18 Inst Rech Scient Irs Association antiallergique.
GB9202519D0 (en) * 1992-02-06 1992-03-25 Glaxo Group Ltd Medicaments
GB2284761A (en) * 1993-12-03 1995-06-21 Euro Celtique Sa Prophylactic treatment of asthma
KR20010041623A (ko) * 1998-03-05 2001-05-25 니뽄 신야쿠 가부시키가이샤 흡입 투여용 지방 유제
GB0005199D0 (en) * 2000-03-04 2000-04-26 Imp College Innovations Ltd Modulation of histone deacetylase
US7550133B2 (en) * 2002-11-26 2009-06-23 Alexza Pharmaceuticals, Inc. Respiratory drug condensation aerosols and methods of making and using them
US20050026848A1 (en) * 2003-07-31 2005-02-03 Robinson Cynthia B. Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with a methylxanthine derivative for treatment of asthma or chronic obstructive pulmonary disease

Also Published As

Publication number Publication date
GB0620840D0 (en) 2006-12-13
AU2005268668B2 (en) 2011-03-24
GB0417481D0 (en) 2004-09-08
NZ552899A (en) 2010-10-29
AU2005268668A1 (en) 2006-02-09
GB2430623A (en) 2007-04-04
CN101035538A (zh) 2007-09-12
MX2007001567A (es) 2008-03-05
CA2576107A1 (en) 2006-02-09
ZA200701007B (en) 2008-07-30
JP2008509119A (ja) 2008-03-27
US20080318912A1 (en) 2008-12-25
RU2395284C2 (ru) 2010-07-27
NO20070597L (no) 2007-05-04
RU2007107915A (ru) 2008-09-10
WO2006013359A1 (en) 2006-02-09
IL180931A0 (en) 2007-07-24
EP1773342A1 (en) 2007-04-18

Similar Documents

Publication Publication Date Title
BRPI0514043A (pt) medicamentos para tratar doença respiratória crÈnica
CY1108978T1 (el) Συνδυασμος ενωσεων μεθυλξανθινης και στεροειδων για να θεραπευονται χρονιες αναπνευστικες ασθενειες
BR112015029918A2 (pt) uso de alta dose de pridopidina para tratar a doença de huntington
CL2008000500A1 (es) Combinacion farmaceutica que comprende una combinacion de dos o mas broncodilatadores o una combinacion de al menos un broncodilatador y al menos un corticosteroide; uso para tratar o prevenir una enfermedad respiratoria; e inhalador que comprende di
BRPI0507966A (pt) uso de meloxicam para o tratamento de doenças respiratórias em porcos
CL2007003520A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso para el tratamiento profilactico o terapeutico del cancer.
CL2007003523A1 (es) Compuestos derivados de heterociclos sustituidos con morfolina, inhibidores de la actividad de pi3 quinasa; composicion farmaceutica que comprende a dichos compuestos; kit farmaceutico; y su uso en el tratamiento profilactico o terapeutico del cancer
BR112015012197A2 (pt) terapia de combinação
BR112015029512A2 (pt) derivados de pirazolopirrolidina e seu uso no tratamento de doenças
AR085662A1 (es) Metodos y composiciones para tratar la hiperuricemia y trastornos metabolicos asociados con la hiperuricemia
BR112014004741A2 (pt) pelo menos uma entidade química; composição farmacêutica; uso de uma quantidade terapeuticamente eficaz de pelo menos uma entidade química; composição farmacêutica embalada
BR112012000862A8 (pt) composição farmacêutica oral, composição farmacêutica oral de baixa dose para administração crônica, método de tratamento ou retardo do inicio ou desenvolvimento de uma condição, método de tratamento da dor em um indivíduo que necessita deste medicamento, método de tratamento de uma condição em um indivíduo que necessita deste medicamento
BR112017006272A2 (pt) composição farmacêutica para tratar colite ulcerativa.
BR112019002513A2 (pt) uso e dosagem de agentes terapêuticos para endometriose
BR112018068784A2 (pt) método para o tratamento de leucemia
BRPI0916282B8 (pt) uso de um agonista do receptor-pgi2 no tratamento de insuficiência renal crônica
BRPI0912112B8 (pt) composição farmacêutica compreendendo composto tendo atividade antagonística em receptor de adenosina a2a útil em suprimir tolerância analgésica
BRPI0712561B8 (pt) Uso de 3-oxo-3,4-diidro-2-pirazinacarboxamida
EA201170405A1 (ru) Монотерпены для лечения заболеваний дыхательных путей, в частности, бронхолегочных заболеваний
BR112015012497A2 (pt) combinações farmacêuticas
PH12015502655A1 (en) Method
AR061477A1 (es) Metodos para utilizar un derivado de tiazol
BRPI0520797B8 (pt) forma de dosagem farmacêutica comprimida em bicamadas
PT1220676E (pt) Prevencao do cancro colorrectal
BRPI0418801A (pt) métodos de tratamento, controle ou prevenção de um cáncer especìfico, e de uma doença associada com angiogênese indesejada, de redução ou prevenção de um efeito adverso, composição farmacêutica, e, kit

Legal Events

Date Code Title Description
B25D Requested change of name of applicant approved

Owner name: PULMAGEN THERAPEUTICS (SYNERGY) LIMITED (GB)

Free format text: NOME ALTERADO DE: ARGENTA DISCOVERY LIMITED

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2260 DE 29/04/2014.